US 10975064
RIP1 inhibitory compounds and methods for making and using the same
granted A61PA61P29/00A61P37/02
Quick answer
US patent 10975064 (RIP1 inhibitory compounds and methods for making and using the same) held by Rigel Pharmaceuticals, Inc. expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P29/00, A61P37/02